Once arthritis was established (4 weeks after the initial injection), bortezomib was given intraperitoneally twice a week for 2 weeks at 0.01, 0.1 or 1.0 mg/kg. Control (non-CIA) and untreated ...

Get detailed information on Bortezomib, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

A study has shown that bortezomib can enhance the activity of doxorubicin-based chemotherapy for the treatment of activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL). This ...